Abstract:Objective To investigate the antitumor mechanism of histone deacetylase (HDAC) inhibitor trichostatin A (TSA) via hypoxia-inducible factor-2α (HIF-2α). Methods Osteosarcoma MG-63 cells were cultured under the hypoxia condition in vitro, and then treated with TSA. The effects of TSA at different concentrations on the expression of HIF-2α, vascular endothelial growth factor (VEGF) messenger RNA (mRNA) and glucose transporter-1 (GLUT-1) mRNA were tested by reverse transcription polymerase chain reaction (RT-PCR) and Western blotting. MG-63 cells and von Hippel-Lindau (VHL) deficient 786-0 cells were treated by the proteasome inhibitor MG132, and the effects of TSA on the expression of HIF-2α were tested by western blotting. Osteosarcoma MG-63 cells were injected subcutaneously into nude mice. When tumors were about 20 mm3 in size, the mice were randomly divided into 2 groups: TSA group (N=6) and normal saline group (N=6). The mice were dosed each 3 days. The tumor tissue morphology was observed under the microscope 17 days later. After the mice were sacrificed, the protein was extracted from the tumor tissues, and the expression of HIF-2α was tested by western blotting. Results In cultured MG-63 cell lines, TSA inhibited the expression of HIF-2α, VEGF mRNA and Glut-1 mRNA in a concentration-dependent manner under the hypoxia condition in vitro; The proteasome inhibitor MG132 could reverse the inhibitory effects of TSA on HIF-2α. In VHL deficient 786-0 cell lines, TSA could also inhibit the HIF-2α expression in a concentration-dependent manner, and MG132 could reverse the effects. In animal xenografts, TSA inhibited the expression of HIF-2α. Conclusions The experiments show that TSA inhibits the HIF-2α expression by a VHL-independent but proteasome-dependent pathway, which suggests that the anticancer effects of TSA are partially mediated by its inhibition of HIF-2α. It provides new insights into the molecular mechanism of the antitumor effects of HDAC inhibitors.

Research of Trichostatin A in Treating Bladder Cancer

Trichostatin A Promotes Bladder Cancer Cell Apoptosis And Inhibits Cell Autophagy Through Mek/Erk Signaling Pathway

Molecular Mechanisms of Trichostatin A Inhibiting the Proliferation of Breast Cancer Cells

Trichostatin C Synergistically Interacts with DNMT Inhibitor to Induce Antineoplastic Effect via Inhibition of Axl in Bladder and Lung Cancer Cells

Trichostatin A Increases Radiosensitivity of Non-small Cell Lung Cancer A549 Cells

HDAC Inhibitor TSA Induced Apoptosis and Growth Arrest in Breast Cancer Cells

Anti-tumor Effects and Cell Motility Inhibition of the DN604-gemcitabine Combined Treatment in Human Bladder Cancer Models.

Effect of Trichostatin A on proliferation and migration of vascular smooth muscle cells

Effects of histone deacetylase inhibitor on colon cancer cell growth and ID4 gene expression

Histone deacetylase inhibitor, trichostatin A, increases the chemosensitivity of anticancer drugs in gastric cancer cell lines

Experimental study on treatment of bladder cancer with a combination of TRAIL and chemotherapeutic agents

Trichostatin A Induces Autophagy in Cervical Cancer Cells by Regulating the PRMT5-STC1-TRPV6-JNK Pathway

The Use of Histone Deacetylase Inhibitor Fk228 and Dna Hypomethylation Agent 5-Azacytidine in Human Bladder Cancer Therapy

Sensitization to γ-irradiation-induced cell cycle arrest and apoptosis by the histone deacetylase inhibitor trichostatin A in non-small cell lung cancer (NSCLC) cells

Effect of trichostatin A on the proliferation and migration of osteosarcoma cell lines and its mechanism

Trichostatin A Inhibits Proliferation and Induces Expression of P21waf and P27 in Human Brain Tumor Cell Lines.

Mechanism and effect of trichostatin A on apoptosis of cisplatin-resistant human lung adenocarcinoma cell line

An experimental study in vivo and in vitro on the antitumor activity of trichostatin A visa hypoxia-inducible factor-2α

The Study of the Effect of Three Different Mechanisms Drugs Single and Combinated on Bladder Cancer Cells

Inhibition of EGFR/PI3K/AKT Cell Survival Pathway Promotes TSA's Effect on Cell Death and Migration in Human Ovarian Cancer Cells.

Trichostatin A Inhibits Proliferation of Triple Negative Breast Cancer Cells by Inducing Cell Cycle Arrest and Apoptosis.